CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-19 | Lowenthal Richard E PRESIDENT AND CEO | Exercise or conversion | +69,444 | $1.44 | $100K | 4,315,313 |
| 2024-04-19 | Lowenthal Richard E PRESIDENT AND CEO | Exercise or conversion · Stock Option (right to buy) | −119,047 | 117,333 | ||
| 2024-04-19 | Lowenthal Richard E PRESIDENT AND CEO | Exercise or conversion · Stock Option (right to buy) | −69,444 | 166,936 | ||
| 2024-04-16 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,647,447 |
| 2024-04-16 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,848,499 |
| 2024-04-16 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,647,447 |
| 2024-04-16 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,848,499 |
| 2024-04-09 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,646,494 |
| 2024-04-09 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,898,499 |
| 2024-04-09 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,646,494 |
| 2024-04-09 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $9.28 | $464K | 1,898,499 |
| 2024-03-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +505,954 | $9.79 | $5.0M | 9,958,073 |
| 2024-03-26 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +457,745 | $9.55 | $4.4M | 9,452,119 |
| 2024-03-25 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +437,600 | $9.06 | $4.0M | 8,994,374 |
| 2024-03-25 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −47,635 | $9.12 | $435K | 1,697,447 |
| 2024-03-25 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −47,632 | $9.12 | $435K | 1,948,499 |
| 2024-03-25 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −47,635 | $9.12 | $435K | 1,697,447 |
| 2024-03-25 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −47,632 | $9.12 | $435K | 1,948,499 |
| 2024-03-22 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −1,017 | $9.03 | $9K | 1,745,082 |
| 2024-03-22 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −1,326 | $9.01 | $12K | 1,996,131 |
Page 17 of 31 · 602 trades